Latest News
BlackRock is overhauling its flagship quantitative investment strategy in a bid to compete more directly with traditional hedge-fund heavyweights, according to a report by the Financial Times.
Man Group, the world’s largest listed hedge fund manager, plans to reduce its London-based workforce and relocate certain roles to its operations base in Bulgaria, signalling an accelerated cost-efficiency drive, according to a report by the Financial Times.
Hedge funds posted a 1.42% gross return in October, according to the Hedge Fund Performance Index from SS&C GlobeOp, one of the industry’s largest administrators, servicing funds representing roughly 10% of global hedge fund assets.
TOP STORY: Michael Burry, the investor famed for his prescient bet against the US housing market that inspired the film The Big Short, has closed his firm Scion Asset Management, liquidating its funds and returning capital to investors, according to a report by Reuters citing a letter to investors.
Haruko, a provider of institutional digital assets technology, has integrated with EDX Markets’ spot trading venue and EDXM International’s perpetual futures exchange. The move is designed to strengthen risk and portfolio management capabilities for institutional clients.
Dymon Asia has hired former Eisler Capital managing director James Meenan as multi-strategy hedge funds continue to compete for senior recruiters, according to a report by Financial News London. Meenan previously spent three years in business development at Eisler before leaving earlier this year.
Brian Kahn, the former head of Franchise Group Inc, has been charged with conspiracy to commit securities fraud in connection with the collapse of Prophecy Asset Management, a hedge fund prosecutors say defrauded investors out of $294m, according to a report by Bloomberg.
One Oak Capital Management, LLC, a registered investment adviser providing fixed income solutions to individuals, institutions, and RIAs, has appointed Joseph H Marren as its Head of Research.
Shah Capital is pressing biotech firm Novavax’s board to explore strategic options, including a full sale, and warns it may launch a proxy fight if changes aren’t made within four months, according to a report by Reuters. The investor has recently increased its share in Novavax to 8.3%, up from 7.2% in October.
The US Securities and Exchange Commission is reconsidering its implementation of the sweeping central-clearing rule for US Treasuries, according to a report by Bloomberg. Agency staff are evaluating possible broadening of the inter-affiliate exemption, which could extend relief to cash transactions and certain affiliate trades.
